|
| |
-
Review of neutropenia management in older cancer
patients, prepared August 2008. [FR, collaborating writer]
-
Detailed abstracts of published journal articles about
anti-angiogenic therapy in breast, colorectal, ovarian, and renal cancer,
prepared June 2008 to September 2008. [FR, writer]
-
CME newsletter on treatment of indolent non-Hodgkin’s
lymphoma, prepared June 2008. [FR, writer]
-
Educational materials for sales representatives about
targeted therapy for non–small-cell lung cancer and pancreatic cancer, prepared June
2008. [FR, writer]
-
Quantitative literature analysis about an anti-anemia
drug, prepared May 2008. [BC, researcher]
-
Three posters for ASCO about anti-angiogenic treatment of breast and
ovarian cancer, prepared April 2008. [FR, collaborating writer]
-
Review about the use of hematopoietic growth factors
to aid recovery from acute radiation syndrome, prepared March 2008. [FR,
collaborating writer]
-
Slide libraries summarizing all major clinical trials
on the use of bisphosphonates to treat skeletal-related events in breast,
lung, prostate, and renal cancer and multiple myeloma, prepared December
2007 to July 2008. [BAC and FR, writers]
-
Caley, BA. The new sarcoma story: strategies for diagnosing and treating
sarcomas shift to a more patient-specific approach. CURE: Cancer Updates,
Research and Education. 2007;6(5):42-49.
-
Hematologic Diseases and Disorders (teaching slides
for geriatrics residents). American Geriatrics Society, www.frycomm.com/ags/teachingslides,
July 2007. [BAC and FR, writers]
-
Qualitative literature review on VATS lobectomy,
prepared May 2007. [FR, researcher]
-
Educational website content for cancer patients,
prepared January to June 2007. [BAC, writer]
Colorectal Cancer
Non–small-cell Lung Cancer
Small-cell Lung Cancer
New Discoveries in Cancer (biologic and targeted therapies,
gene therapy, therapeutic vaccines, and individualized treatment)
-
Recent developments in the treatment of aggressive
non-Hodgkin’s lymphoma. Review prepared June 2007. [FR, collaborating
writer]
-
Oncology (teaching
slides for geriatrics residents). American Geriatrics Society,
www.frycomm.com/ags/teachingslides, April 2007. [BAC and FR, writers]
-
Caley BA. Surgeons and
robots: minimally invasive technologies transform
the landscape of cancer surgery. CURE: Cancer Updates, Research and
Education. 2007;6(4). Also wrote sidebar: Less can be more in diagnostic
imaging.
-
Journal supplement about identification and treatment
of oral mucositis, prepared January 2007. [FR, collaborating writer]
-
Pathology and staging:
how much, what it looks like and where it is guide
diagnosis and treatment. CURE: Cancer Updates, Research and
Education. 2007;6(1):8,11-13.
[BAC, writer]
-
Supplement to European Journal of Oncology Nursing, 3
articles about identification and treatment of oral mucositis, prepared
January 2007. [FR, collaborating writer]
-
Caley BA. Bladder cancer: breaking the research barrier. CURE: Cancer
Updates, Research and Education. 2006;5(5):34-39,44-45.
-
Investigator newsletters reporting on clinical trials
of a therapy for oral mucositis, prepared September 2006 and March 2007. [FR,
writer]
-
Poster for ASCO about outcome measures for clinical
trials of agents for metastatic colorectal cancer, prepared April 2006. [FR,
collaborating writer]
-
CME newsletter about the burden of cervical cancer,
prepared September 2006. [FR, writer]
-
Caley BA. In situ breast cancer: is it really cancer?
CURE: Cancer Updates, Research and Education.2006;5(4):18-23,28. Also wrote sidebar: Do
women
under 50 need
mammograms?
-
Quantitative literature review on prevention of
anemia, prepared May 2006. [BAC, researcher]
-
Quantitative literature review on angiogenesis
inhibitors, prepared May 2006. [BAC, researcher]
-
The health consequences of smoking. In: Attorneys’ Textbook of Medicine. New York, NY: Matthew Bender, 2006. [BAC,
substantive editor]
-
Caley BA. Taking control: cancer patients deal with fear. CURE: Cancer
Updates, Research and Education. 2006;5(3):64-68.
-
Review about the safety of testosterone replacement
therapy with regard to prostate cancer, prepared April 2006. [BAC and FR,
collaborating writers]
-
Caley BA.
Picking up momentum for treating renal cell carcinoma.
CURE: Cancer Updates, Research and Education. 2006;5(1):34-42.
-
Review about the safety of using an antiangiogenic
agent in metastatic colorectal cancer, prepared March 2006. [FR,
collaborating writer]
-
Review about the use of an antiangiogenic agent in
elderly patients or patients with poor performance status, prepared January
2006. [FR, collaborating writer]
-
Meeting report, national advisory board on
angiogenesis inhibitors, prepared December 2005. [FR, writer]
-
Report on current standards of care for prostate,
pancreatic, and head and neck cancer, and carcinoid tumor, prepared November
2005. [FR, writer]
-
Caley BA.
The future of cancer
research: recent discoveries will change the direction of treatment.
CURE: Cancer Updates, Research and Education. 2005;4(4):48-55.
-
Preventing death from breast cancer and prostate
cancer. Prepared for Taking Care, November 2005. [BAC, writer]
-
Are thyroid nodules cancerous? Prepared for Taking
Care, October 2005. [BAC, writer]
-
Meeting report, national advisory board on supportive
care in cancer, prepared September 2005. [FR, writer]
-
Review about trends in chemotherapy for lung cancer,
prepared July 2005. [FR, collaborating writer]
-
Caley BA. Going against the odds [living with
metastatic cancer]. CURE: Cancer Updates, Research and Education. 2005;4(2):56-58,60.
Also wrote
two of the three sidebars to this article: Disrupting metastasis; The future
of metastasis treatment.
-
Meeting report, national breast cancer advisory board,
prepared June 2005. [FR, writer]
-
Posters for ASH, ASCO, and MASCC/ISOO annual meetings,
2005. Multiple topics regarding supportive care for cancer patients. [FR,
writer]
-
Quantitative literature analyses about: a
hematopoietic growth factor (prepared April 2005), a novel leukemia drug
(March 2005), a novel taxane (February 2005), monoclonal antibodies for
breast cancer (February 2005), a novel anthracenedione (February 2005), and
various antimicrobials (January 2005). [BAC, researcher]
-
Caley BA. Hodgkin’s
disease: the other side.
CURE: Cancer Updates, Research and Education.
2005;4(1):40-47.
-
Monograph on
the treatment of multiple myeloma, prepared December 2004. [BAC and FR,
writers]
-
Educational newsletter for sales representatives about
targeted therapy, prepared Spring 2004. [FR, writer]
-
Caley BA. Singling
out sarcoma: why everyone should care about this uncommon disease.
CURE: Cancer Updates, Research and Education. 2004;3(2):56-60, 62-63.
-
Meeting report, national breast cancer advisory board,
prepared June 2004. [BAC, writer]
-
Quantitative literature analysis regarding
chemotherapy for non-small-cell lung cancer, prepared April 2004. [BAC,
researcher]
-
Posters for ASCO and MASCC/ISOO annual meetings, 2004.
Multiple topics regarding supportive care for cancer patients. [FR,
collaborating writer]
-
Herman R. Cultural diversity and cancer patient
education. Poster presented at the 2004 annual meeting of the Oncology
Nursing Society. [FR, collaborating writer]
-
Caley BA. The future of hemophilia therapy: will it be
safer and easier? HemAware. 2003;8(6):50-53.
-
Caley BA and Reidenbach F. Growing older with
hemophilia: a lifetime of bleeds creates problems. HemAware.
2003;8(4):59-63.
-
Caley BA and Reidenbach F. Night splints: an option
for treating chronic muscle tightness in people with hemophilia. HemAware.
2003;8(3):53-55.
-
Walsh JME. Controversies in cancer prevention and
screening. Adv Stud Med. 2003;3(6):316-325.
[BAC and FR, collaborating writers]
-
Caley BA and Reidenbach F. Expanding options for advanced breast cancer.
CURE: Cancer Updates, Research and Education. 2003;2(3):47-53.
-
National Anemia
Action Council, 2002-2003. Wrote news for a physician website (http://www.anemia.org),
wrote slide sets for a speakers bureau, and edited a monograph on the
epidemiology, diagnosis, and treatment of anemia. Wrote news and a glossary
for the launch of a consumer website and produced patient education
materials. [BAC and FR]
-
Reidenbach F.
Conceiving solutions: Fertility and cancer
treatment.
CURE: Cancer Updates, Research and Education.
2002;1(4):22-26.
-
Reidenbach F. Deep
in the bone: Managing multiple myeloma.
CURE: Cancer Updates, Research and Education.
2002;1(2):30-38.
-
Reidenbach F.
Novel drug delivery device may improve liver cancer outcomes. Lancet
Oncol. 2002;3:450.
-
Reidenbach F.
Gabapentin may relieve tamoxifen-related hot flushes. Lancet Oncol.
2002;3:393.
-
Reidenbach F.
Researchers recommend early use of implantable drug pump. Lancet Oncol.
2002;3:386.
-
Reidenbach F.
Chemotherapy safe in pregnancy. Lancet Oncol. 2002;3:128.
-
Boosting immunity
to cancer through nutrition. Women's Health Advisor. 1998;2(1):7.
[FR, writer]
Bylined news reports
distributed on Reuters Health wire service
[FR, writer]:
-
Telomerase
immunoreactivity of prostate tumors may have diagnostic value, 12-27-2002.
-
Novel
apoptosis stimulators developed from COX-2 inhibitors, 12-13-2002.
-
Angiogenesis
inhibitor plus paclitaxel well tolerated in phase I trial, 12-5-2002.
-
Novel
predictor of breast cancer survival called the most powerful to date,
11-14-2002.
-
CD34-selected
stem cell transplantation safe for rheumatoid arthritis patients,
10-15-2002.
-
Resistance to
antiangiogenic agents may reflect variance in tumor biology, 10-03-2002.
-
First cholinergic pathway for angiogenesis identified,
9-10-2002.
-
Gleevec and other c-Kit inhibitors might treat
Kaposi’s sarcoma, 8-22-2002.
-
St. John’s wort
alters metabolism of chemotherapeutic agent irinotecan, 8-21-2002.
-
Early radiation
advised for limited-stage small-cell lung cancer, 8-7-2002.
-
Spiral CT
promising for lung cancer screening, 8-2-2002.
-
Cannabinoid receptor agonists may be novel class of
anti-lymphoma agents, 7-25-2002.
-
Cytokine improves immune function after bone marrow
transplantation in mice, 7-5-2002.
-
Public funding of Pap tests linked to lower rate of
invasive cervical cancer, 7-5-2002.
-
Lymphoma not
common in rheumatoid arthritis patients receiving methotrexate, 6-24-2002.
-
Childhood AML can
begin in utero with latency as long as 12 years, 6-3-2002.
-
Single clone
remains dominant in paroxysmal nocturnal hemoglobinuria, 5-1-2002.
-
Anthracycline/taxane
neoadjuvant chemotherapy advised for breast cancer,
4-9-2002.
-
Statins might fight
spread of pancreatic cancer,
3-29-2002.
-
Idiotype-pulsed
dendritic cell vaccination can induce regression of B-cell
NHL,
3-27-2002.
-
Bone marrow
defects seen in RA, might hinder experimental therapies, 3-22-2002.
-
p53 appears to inhibit
angiogenesis in non-small-cell lung cancer,
3-13-2002.
-
Gene may help suppress
colorectal cancer,
2-28-2002.
-
Common virus linked to
childhood brain tumor,
2-19-2002.
-
Exposure to TNF-alpha
boosts tumor angiostatin production in murine model,
2-19-2002.
-
HHV-6 in cerebrospinal
fluid can cause encephalitis after stem cell transplantation,
2-19-2002.
-
Type of childhood
leukemia linked to parental age,
2-15-2002.
-
Mental difficulties can
persist long after chemotherapy,
2-11-2002.
-
Clues to why breast
cancer more fatal in blacks,
2-7-2002.
-
Postmastectomy radiation
may be warranted after response to chemotherapy,
1-30-2002.
-
Some lab values may
predict response to hydroxyurea in sickle cell anemia,
1-29-2002.
-
Capecitabine promising
for advanced renal cell carcinoma,
1-23-2002.
-
DNA repair ability
affects risk of melanoma,
1-16-2002.
-
Adult stem cells from
murine skeletal muscle can become blood cells,
12-6-1999.
-
Addition of
cyclophosphamide could improve virus therapy for brain tumors,
7-27-1999.
-
Enhanced Pap
testing cost effective for infrequent screening, 1-27-1999.
-
Calcium reduces risk of
colorectal polyps,
1-13-1999.
-
Chronic fatigue
prevalent among survivors of Hodgkin’s disease,
1-13-1999.
-
Gene affects immune
response to cancer,
12-25-1998.
-
Depression tied to
cancer risk in elderly,
12-15-1998.
-
Survivin seems to be an
advantage factor for tumor cell expansion,
12-10-1998.
-
Incident breast lesions
found on MRI unlikely to be malignant,
12-2-1998.
-
Proto-oncogene PML
regulates immune response to tumor cells,
11-26-1998.
-
Adjuvant chemo prolongs
survival in high-risk node-negative breast cancer,
10-30-1998.
-
Blood test may
screen for ovarian cancer, 8-25-1998.
-
Clinical findings
predict DNA-repair gene mutations in colorectal cancer,
8-20-1998.
-
Level of p27 predicts
outcome in localized prostate cancer,
6-17-1998.
-
Tumor suppressor gene
PTEN affects cell-surface interactions,
6-8-1998.
-
Modified PKC ribozyme
resists nuclease without loss of efficacy,
6-1-1998.
-
Blood test may detect
cancer early,
4-13-1998.
-
More genetic links to
breast cancer,
3-31-1998.
• Home • Bev Caley • Faith Reidenbach • Services • What We've Written • Client Experience • What Our Clients Say •
|